10/17/2024 11:31 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 6:58 PM | Bailey Webster (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 7:01 PM | Lacey John III (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 7:06 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 5:56 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 5:58 PM | Provectus Biopharmaceuticals (Issuer) Rodrigues Dominic (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 4:21 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
08/30/2024 8:54 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/27/2024 10:15 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 2:06 PM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 6:23 PM | Morris Jeffrey Allen (Filed by) Provectus Biopharmaceuticals (Subject)
| Form SC 13G | |
08/14/2024 6:19 PM | Morris Jeffrey Allen (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 12:21 PM | Provectus Biopharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024 2:31 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/23/2024 4:20 PM | Provectus Biopharmaceuticals (Issuer) Rodrigues Dominic (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2024 2:24 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 12:02 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 2:50 PM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2024 6:29 PM | Pershing Edward (Filed by) Provectus Biopharmaceuticals (Subject)
| Form SC 13D | |
07/02/2024 9:37 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 5:46 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 2:41 PM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2024 12:56 PM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2024 1:08 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 8:30 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2024 5:03 AM | Provectus Biopharmaceuticals (Filer)
| Form DEFA14A | |
06/17/2024 4:58 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 4:32 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 1:43 PM | Provectus Biopharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024 12:33 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 9:54 AM | Provectus Biopharmaceuticals (Filer)
| Form ARS | |
05/06/2024 12:56 PM | Provectus Biopharmaceuticals (Filer)
| Form DEF 14A | |
05/06/2024 12:57 PM | Provectus Biopharmaceuticals (Filer)
| Form DEFA14A | |
04/30/2024 11:20 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 12:10 PM | Provectus Biopharmaceuticals (Filer)
| Form 10-K/A | |
04/26/2024 10:48 AM | Provectus Biopharmaceuticals (Filer)
| Form PRE 14A | |
04/26/2024 8:00 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 10:08 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 3:58 PM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/15/2024 2:45 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2024 3:31 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
[Urgent] Starlink Set For The Largest IPO In History? (Ad) He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant.
Then, he did it again with Tesla… which is up more than 19,500% since 2010.
For perspective, that turns $100 invested into almost $20,000!
And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet.
And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO. Click here now for the urgent details on this hidden play. |
03/28/2024 1:35 PM | Provectus Biopharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/27/2024 11:10 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2024 3:48 PM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2024 3:49 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 9:58 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 4:29 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 8:22 AM | Provectus Biopharmaceuticals (Issuer) Raines Heather (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 2:16 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 1:12 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 8:30 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 10:12 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:54 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 7:05 AM | Provectus Biopharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/06/2024 2:16 PM | Provectus Biopharmaceuticals (Issuer) Raines Heather (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 4:29 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 3:21 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 1:55 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 10:39 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 11:49 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 5:51 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 4:23 PM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 10:35 AM | Provectus Biopharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023 8:00 AM | Pershing Edward (Reporting) Provectus Biopharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |